Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon γ and all-trans retinoic acid

Biological Chemistry

Volumn 379, Issue 8-9, 1998, Pages 1083-1091

  Müschen, Markus ^a   Warskulat, Ulrich ^a   Schmidt, Bettina ^a   Schulz, Wolfgang A ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antitumor immunity; Apoptosis; Differentiation; Interleukin 1 converting enzyme; Matrix metalloproteinase

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; MESSENGER RNA; RECEPTOR; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL CELL; CELL ACTIVATION; CELL DIFFERENTIATION; EMBRYO; EMBRYONAL CARCINOMA STEM CELL; JURKAT CELL LINE; NONHUMAN; RAT; STABLE EXPRESSION; T LYMPHOCYTE;

EID: 0031686257     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1998.379.8-9.1083     Document Type: Article

References (32)

1. Ancuta, P., Fahmi, H., Pons, J.F., Le Blay, K., and Chaby, R. (1997). Involvement of the membrane form of tumor necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide. Immunology. 92, 259-266.
2. Andrews, P.W. (1987). Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103, 285-293.
3. Andrews, P.W., Damjanov, I., Simon, D., Banting, G.S., Carlin, C., Dracopoli, N.C., et al. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Lab. Invest. 50, 147-152.
4. Arai, H., Chan, S.Y., Bishop, D.K., and Nabel, G.J. (1997). Inhibition of the alloantibody response by CD95 ligand. Nature Med. 3, 843-848.
5. Bissonnette, R.P., Brunner, T., Lazarchik, S.B., Yoo, N.Y., Boehm, M.F., Green, D.R., and Heyman, R.A. (1995). 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of Fas ligand and requires retinoic acid receptors retinoic X receptor Activation. Mol. Cell. Biol. 15, 5576-5585.
6. Chambaut-Guérin, A.-M., Martinez, M.-C., Hamimi, C., Gauthereau, X., and Nunez, J. (1995). Tumor necrosis factor receptors in neuroblastoma SKNBE cells and their regulation by retinoic acid. J. Neurochem. 65, 537-544.
7. Enari, M., Hase, A., and Nagata, S. (1995). Apoptosis by a cytosolic extract from Fas-activated cells. EMBO 14, 5201-5208.
8. Griffith, T., Brunner, T., Fletcher, S., Green, D.G., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
9. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L.E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J.C., and Tschopp, J. (1996). Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274, 1363-1366.
10. Hug, H. (1997). Fas mediated apoptosis in tumor formation and defense. Biol. Chem. 378, 1405-1412.
11. Hughes, D.P.M., and Crispe, N.I.A. (1995). Naturally occurring soluble isoform of murine CD95 generated by alternative splicing. J. Exp. Med. 182, 1395-1401.
12. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
13. Keane, M.M., Ettenberg, A., Lowrey, G.A., Russel, E.K., and Lipkowitz, S. (1996). Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56, 4791-4798.
14. Kohchi, C., Noguchi, K., Tanabe, Y., Mizuno, D.-I., and Soma, G.-I. (1994). Constitutive expression of TNF-alpha and beta genes in mouse embryo: Roles of cytokines as regulator and effector on development. Int. J. Biochem. 26, 111-119.
15. Lee, J., Richburg, J.H., Youngkin, S.C., and Boekelheide, K. (1997). The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology 138, 2081-2088.
16. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K.-M., Krammer, P.H., and Müller, P. (1993). Constitutive and induced expression of APO-1, a new member of the nerve growth factor / tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429.
17. Midis, G.P., Shen, Y., and Owen-Schaub, L.B. (1996). Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res. 56, 3870-3874.
18. 3. Biol. Chem. 377, 703-710.
19. Müschen, M., Warskulat, U., Douillard, P., Gilbert, E., and Häussinger, D. (1998). Regulation of CD95 (Apo-1/Fas) receptor and ligand expression in parenchymal and non parenchymal rat liver cells. Hepatology 27, 200-208.
20. Nikawa, T., Schulz, W.A., van den Brink, C.E., Hanusch, M., van der Saag, P., Stahl, W., and Sies, H. (1995). Efficacy of all-trans-β-carotene, canthaxanthin, and all-trans-, 9-cis, and 4-oxo-retinoic acids in inducing differentiation of an F9 embryonal carcinoma RARβ-lacZ reporter cell line. Arch. Biochem. Biophys. 297, 197-205.
21. O'Connell, J., O'Sullivan, G.G., Collins, J.K., and Shanahan, F. (1996). The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184, 1075-1082.
22. Okazawa, H., Shimizu, J., Kamei, M., Imafuku, I., Hamada, H., and Kanazawa, I. (1996). Bcl-2 Inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J. Cell. Biol. 132, 955-968.
23. Pannetier, C., Delassus, S., Darche, S., Saucier, C., and Kourilsky, P. (1993). Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucl. Acids Res. 21, 577-583.
24. Schlottmann, K., and Coggeshall, K.M. (1996). CD95/Fas/Apo-1-mediated signal transduction. Cell Physiol. Biochem. 6, 345-360.
25. Seino, K.-I., Kayagaki, N., Okumura, K., and Yagita, H. (1997). Antitumor effect of locally produced CD95 ligand. Nature Med. 3, 165-170.
26. Stopper, H., Eckert, I., Wagener, P., and Schulz, W.A. (1997). Formation of micronuclei and inhibition of topoisomerase II in the comet assay in mammalian cells with altered DNA methylation. Rec. Results Cancer Res. 143, 183-193.
27. Strand, S., Hoffmann, W.J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H., and Galle, P.R. (1996). Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nature Med. 2, 1361-1366.
28. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M. Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H., and Nagata, S. (1996). Fas ligand in human serum. Nature Med. 2, 317-322.
29. Tomita, T., Kawasaki, T., Bilim, V., Takeda, M., and Takahashi, K. (1996). Tetrapeptide DEVD-aldehyde or YVAD-chlormethylketone inhibits Fas/Apo-1 (CD95)- mediated apoptosis in renal cancer cells. Int. J. Cancer 68, 132-135.
30. Walker, P.R., Saas, P., and Dietrich, P.Y. (1997). Role of Fas ligand (CD95L) in immune escape. The tumor cell strikes back. J. Immunol. 158, 4521-4524.
31. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
32. Yang, Y., Minucci, S., Ozato, K., Heyman, R.A., and Ashwell, J.D. (1995). Efficient inhibition of activation induced Fas ligand upregulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoid acid receptors. J. Biol. Chem. 270, 18672-18677.